- €284.36m
- €493.62m
- €736.20m
- 73
- 50
- 71
- 74
2019 February 28th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 782 | 527 | 498 | 607 | 736 |
Cost of Revenue | |||||
Gross Profit | 80.4 | 7.49 | 34.5 | 48.3 | 89.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 738 | 601 | 523 | 602 | 719 |
Operating Profit | 43.6 | -74.4 | -25.1 | 5.47 | 17.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 36.8 | -81.2 | -30.5 | -3.14 | 0.007 |
Provision for Income Taxes | |||||
Net Income After Taxes | 30.3 | -77 | -23.6 | -0.984 | 9.11 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 30.3 | -77 | -23.6 | -0.984 | 9.11 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 30.3 | -77 | -23.6 | -0.984 | 9.11 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.94 | -0.801 | 0.319 | -0.007 | 0.199 |
Dividends per Share |